How to Reconstitute a Research Peptide: A Step-by-Step Guide

Concentration arithmetic from vial mass and diluent volume

The calculation underneath every stock solution is one division followed by one multiplication. Mass of solid in the vial divided by the volume of diluent delivered gives concentration. A target research amount divided by that concentration gives the volume of solution to withdraw. Nothing about the chemistry makes it harder than that, and almost every error that reaches the bench is a unit error rather than an algebra error.

The unit that causes the trouble is the milligram against the microgram. One milligram is one thousand micrograms, and because vial masses are quoted in milligrams while working amounts for many research sequences are quoted in micrograms, a factor of a thousand sits in the middle of the calculation waiting to be dropped. A 10 mg vial brought up in 2.0 mL of diluent is 5 mg per mL, which is the same statement as 5000 micrograms per mL. It is worth writing both forms on the record, because the mixed-unit step is where transcription errors enter and they are invisible once the number has been rounded.

The most useful derived figure is the amount contained in 0.1 mL, because 0.1 mL is a volume that most laboratory transfer devices measure with acceptable relative error and because the conversion is trivial: concentration in mg per mL multiplied by one hundred gives micrograms per 0.1 mL. Five mg per mL is 500 micrograms per 0.1 mL. Two mg per mL is 200 micrograms per 0.1 mL. Building the habit of quoting a stock as micrograms per 0.1 mL rather than mg per mL removes one conversion from the working step, and the working step is the one performed under time pressure.

The reconstitution volume itself deserves more thought than it usually gets, because it is a free parameter. It is chosen by whoever prepares the vial; it is not a property of the material. Choosing it well means choosing it so that the volume routinely withdrawn falls in the range where the transfer device is accurate, which for most devices means mid-scale rather than at either extreme. A stock so concentrated that a routine withdrawal is a few microliters carries a large relative error on every transfer. A stock so dilute that the vial cannot hold the fill, or that adsorptive losses to the container become significant, has traded one problem for another. Between those limits the choice is yours, and it should be made once and recorded rather than improvised per vial.

Two assumptions sit under the whole calculation, and both are routinely false. The first is that the vial contains the labeled mass of peptide. The second is that the volume delivered is the volume present. The next two sections take each in turn.

Concentration reference across common fill masses and reconstitution volumes, assuming the labeled mass is peptide mass

Read the table across rather than down. The two rows at 5 mg per mL come from different fills entirely, which is the point: concentration is set by the ratio, not by either number alone, and a laboratory running several fill sizes can standardize on one working concentration by varying the diluent volume. For any combination not listed, the same two operations apply, and it is worth recomputing rather than interpolating, since the relationship between volume and concentration is reciprocal and interpolating a reciprocal by eye produces errors in the direction of over-concentration.

Net peptide mass is not the labeled mass

A vial described as 10 mg was filled to 10 mg of lyophilized solid. That solid is not pure peptide, and the gap is not a defect. It is an unavoidable consequence of how synthetic peptides are purified and dried, and it is large enough to move a concentration calculation outside most laboratories' acceptable error.

The largest contributor is usually the counter-ion. Reversed-phase purification is conventionally run with trifluoroacetic acid as the ion-pairing additive, and basic residues leave that process paired with trifluoroacetate. Every arginine, lysine and histidine, plus the free N-terminal amine, is a potential site, so the counter-ion burden scales with how basic the sequence is. For basic peptides the trifluoroacetate fraction is commonly reported somewhere in the region of ten to thirty percent of the dry mass, and for a sequence carrying several basic residues it sits at the upper end of that. Some materials are supplied after salt exchange to acetate or hydrochloride, which changes the mass fraction but does not eliminate it.

Residual water is the second contributor. A lyophilized cake is an amorphous solid with an affinity for water, and it retains some even straight from a properly run drying cycle. It picks up more from ambient humidity every time the container is opened. A few percent by mass is unremarkable; a cake that has slumped or gone sticky has taken up considerably more. Where a certificate reports a water determination, that number is a direct deduction from the peptide mass.

The distinction that resolves all of this is between purity and content, and the two are routinely conflated because both are quoted as percentages. Purity from a chromatographic separation is a relative figure: it says what fraction of the peptide-related material detected is the target species. Content is an absolute figure, usually established by amino acid analysis, nitrogen determination or a quantitative measurement against a reference standard, and it says what fraction of the weighed solid is peptide at all. A material can honestly be reported as 99 percent pure and 78 percent peptide content simultaneously. Neither figure is wrong and neither substitutes for the other.

Correcting the arithmetic is straightforward once the content figure exists. Multiply the labeled mass by the content fraction to get net peptide mass, then divide by the delivered volume as before. A 10 mg vial at 80 percent content holds 8 mg of peptide, and in 2.0 mL that is 4 mg per mL rather than the 5 mg per mL the label implies, a twenty percent error in the direction of overestimating how much material every withdrawal contains. If the certificate does not report content, the honest positions are to treat the labeled mass as gross and record that assumption explicitly, or to determine content locally. What is not defensible is applying a correction factor borrowed from a different lot.

Peptide content correction worked through, showing what the same labeled vial actually yields

The correction matters most when results are compared across lots or across suppliers, because content varies with the sequence, the purification and the salt form, and an uncorrected comparison silently compares different amounts of peptide. Within a single lot, an uncorrected figure is at least consistent, which is why some laboratories reasonably choose to work nominally and record that they have done so. The failure mode to avoid is the mixed one: correcting some preparations and not others, with nothing in the record to say which is which.

Wetting the cake without foaming the solution

Where the stream of diluent lands changes how much material ends up in solution, and it changes it by more than most people expect. A stream delivered straight down onto the cake behaves like a jet against a fragile porous solid: it breaks the cake apart and throws fine particles upward, onto the vial wall above the liquid line and onto the underside of the stopper. Material stranded above the meniscus does not dissolve, because it is no longer in contact with the liquid. It becomes a loss that is invisible in the finished solution and that shows up only as a concentration lower than the calculation predicted.

The alternative is to angle the container slightly and let the diluent run down the inner wall so it pools beneath the cake and rises through it. The cake wets from below, capillary action carries liquid into the porous matrix, and nothing is thrown anywhere. This takes a few seconds longer and is the single largest technique-driven difference in recovery available at this step. Delivering slowly also matters because a lyophilized vial is frequently under partial vacuum, and a vial under vacuum draws liquid in faster than the operator is metering it; easing the pressure differential first keeps control of the stream.

Once liquid is in, the temptation is to agitate, and this is where preparations are damaged. Peptides are surface-active molecules. They accumulate at an air-liquid interface, and at that interface they adopt conformations they do not hold in bulk solution, which is the mechanism behind interfacial denaturation and the aggregation that follows it. Vortexing does not merely mix; it draws a funnel of air into the liquid and creates an enormous interfacial area for as long as it runs. Vigorous shaking does the same thing and additionally traps a foam layer that holds solution you cannot recover and hides the meniscus you need to read. Foam is not cosmetic. It is a signal that interfacial material is accumulating and that some fraction of what was in the vial is now in a state it will not fully return from.

What works instead is unglamorous. Swirl gently, with the vial upright, in a slow circular motion that moves the liquid without breaking the surface. Then set the vial down and leave it. Dissolution of a lyophilized cake is largely diffusion-limited, and time does most of the work that agitation is being asked to do. Ten to thirty minutes at ambient temperature dissolves the majority of well-behaved sequences with no intervention beyond an occasional swirl. Warming a refrigerated vial to room temperature before starting helps here for the same reason it prevents condensation, which the article above already covers.

The last point is a volume point. Undissolved solid displaces liquid. A vial that still contains suspended or settled cake reads a meniscus higher than the true solution volume, so any judgment about whether the delivered volume was correct has to wait until dissolution is visibly complete against a light background.

Physical handling choices and their effect on how much peptide reaches solution

The pattern across the table is that every fast method buys time by creating interface, and interface is the currency the peptide pays in. Where a preparation genuinely cannot wait, the correct trade is more time at temperature rather than more energy, because raising temperature accelerates dissolution without generating surface. If a solution has already foamed, letting it stand until the foam collapses recovers some of the trapped liquid, but material that unfolded at the interface does not reliably refold, so the loss is partly permanent.

Why a 2 mL fill does not yield 2 mL

Two different quantities get called the volume of a preparation, and treating them as one number is the second systematic error in reconstitution arithmetic. The first is the volume delivered into the vial, which sets the concentration. The second is the volume that can actually be withdrawn as working aliquots, which is always smaller, sometimes by a margin that matters when the last aliquot is being planned.

The vial holds some of it permanently. There is a heel of liquid at the base that a tip cannot reach without tilting the vial past the point where the tip is above the liquid, and there is a film of solution wetting the entire inner wall and the underside of the stopper. The film is thin, but the wall area of a standard vial is not small, and the film re-forms every time the vial is swirled or inverted. Neither of these is recoverable in normal handling, and both are larger in a tall narrow vial than in a squat one for the same fill.

The transfer path holds more. A needle and its hub retain a volume that stays behind on withdrawal, typically on the order of tens of microliters and entirely dependent on hub geometry and needle length, which means it is a constant you should measure once for your own hardware rather than take from anywhere. A septum absorbs a small amount and holds a droplet at each puncture. Every puncture wets fresh elastomer. Across a dozen withdrawals from one vial these losses add up to a noticeable fraction of a small fill.

The cake itself absorbs. A porous lyophilized matrix wets before it dissolves, and during that interval liquid is held in the matrix rather than in the bulk. In most cases this resolves as dissolution completes, but for a slow-dissolving material the working volume during the first part of the process is genuinely lower than the delivered volume. Foam, if any was created, holds volume in the same way and returns it only as the foam collapses.

The delivered volume is itself uncertain, which compounds everything above. A graduated container read by eye carries a parallax error. A transfer device calibrated for water leaves a residual film in its own tip. Diluents containing benzyl alcohol have a slightly different surface behavior than pure water, which changes the film. None of these is large; together they mean that the number written in the record as the delivered volume is an estimate unless it was verified.

The verification worth doing is gravimetric. Weigh the sealed vial before and after adding diluent. Aqueous diluents are close enough to 1.00 g per mL at ambient temperature that the mass difference in grams is the volume in milliliters to well within the precision of anything else in the process. It takes one balance and about fifteen seconds, and it converts the single most load-bearing number in the concentration calculation from an assumption into a measurement.

Where the delivered volume goes, and what to do about each route

The practical consequence is that a nominal 2.0 mL preparation should be planned as somewhat less than 2.0 mL of deliverable solution, and the shortfall should be absorbed at the planning stage rather than discovered at the last aliquot. If a protocol needs a defined number of equal aliquots, size them against the recoverable volume and treat the remainder as a residue with no assigned use. Weighing the vial before and after is the cheapest way to know which of the two volumes you are actually working with.

When dissolution stalls and what actually helps

Most cakes go into solution with time and a gentle swirl. The ones that do not divide into two populations that need opposite responses, and telling them apart before intervening is the whole skill.

The first population is simply slow. The cake is intact, the liquid is clear, and solid is visibly present but shrinking. The intervention is time and gentle temperature. A vial taken straight from cold storage is dissolving at a temperature where both solubility and diffusion are suppressed; letting it equilibrate to ambient temperature and then giving it another twenty minutes resolves a large fraction of apparent failures. Gentle warming to hand temperature is a reasonable next step for a material with no known thermal sensitivity, applied by placing the vial in a controlled block rather than anything that produces a hot spot at the glass. Aggressive heat is not a dissolution aid; it is a degradation route.

Bath sonication is the next escalation and works because it generates microstreaming that continually refreshes the liquid immediately adjacent to the dissolving solid, which is where the concentration gradient limits the rate. Use it in short intervals of a minute or two with the vial suspended in the bath and not resting on the transducer plate, and check the bath temperature between intervals because sonication baths warm rapidly. Probe sonication is a different technique entirely, delivers cavitation energy directly into the liquid, and is not appropriate for a peptide stock.

The second population is not slow, it is insoluble under the conditions offered. Strongly hydrophobic sequences, sequences with high beta-sheet propensity, and anything with a net charge near zero at the pH of the diluent may never fully dissolve in plain aqueous medium no matter how long they sit. Here the useful levers are pH and co-solvent, and both are chosen from the sequence rather than by trial. An acidic sequence dissolves more readily in a mildly basic aqueous medium; a basic sequence in a mildly acidic one; a sequence with balanced charge is worst served by neutral water because it sits at its own isoelectric point. Very hydrophobic material is conventionally taken up in a minimal volume of an organic co-solvent first and then diluted into the aqueous phase with swirling, never the reverse, since adding water to a concentrated organic solution can precipitate the peptide at the interface.

Both of those interventions carry a cost that has to be recorded. A co-solvent becomes part of the sample matrix for every downstream measurement, may interfere with a concentration assay, and changes the storage behavior of the stock. A pH adjustment changes the chemistry available to labile residues. Neither belongs in a routine preparation; both are legitimate when the sequence requires them and the record says what was done.

The signal that says stop escalating is a solution that has gone opalescent or gelled. That is aggregation, not incomplete dissolution, and more energy makes it worse.

Troubleshooting a preparation that does not look right

The common thread is that clarity is a weak test. It rules out gross precipitation and nothing else, since soluble aggregates can be well below the size that scatters visible light while already representing a substantial change in the material. A preparation that looks fine can still have lost peptide to the wall, to the interface, or to aggregates too small to see. That is an argument for recording appearance as one observation among several rather than treating it as the acceptance criterion.

The preparation record that makes a stock traceable

The value of a record is not that it exists but that it contains the numbers nobody remembers a month later, and specifically the numbers that would let someone reconstruct why a result came out the way it did. For a reconstituted stock, that means the record has to carry three things that are frequently absent: what the starting material actually was, what was actually delivered, and which assumptions were made in the calculation.

Starting material means the lot, not the compound. A sequence name identifies what was ordered; a lot identifies what was in the vial. The certificate associated with that lot carries the purity figure, the identity confirmation, and if you are fortunate the peptide content and water determination that drive the correction described above. Recording the lot and the certificate reference, rather than transcribing the numbers alone, means the source document can be re-read when a question arises rather than trusted from memory.

What was actually delivered means the measured volume where a balance was available and the nominal volume clearly flagged as nominal where it was not. It also means the diluent, by identity and lot, because the diluent is a reagent with its own properties and its own expiry. A stock prepared with a bacteriostatic medium and one prepared with plain sterile water are not interchangeable for purposes of how long the solution is usable, and six weeks later nothing about the vial will tell you which was used.

Which assumptions were made is the part that gets skipped and the part that matters most for comparability. A record that says 5 mg per mL is ambiguous between a nominal figure and a content-corrected one, and those differ by twenty percent for a typical content value. Writing the concentration together with the basis, in one line, removes an entire class of downstream confusion, and it costs nothing at the moment of preparation.

Everything after that is forward traceability, and it depends on a single identifier. Assign each preparation a unique identifier at the moment it is made, put that identifier on the vial and on every aliquot drawn from it, and reference it from every experimental record that consumes material. The point is the reverse lookup: when a result looks anomalous, you want to be able to establish in seconds whether that preparation was the one that took forty minutes to dissolve, or was corrected for content when its neighbors were not, or came from the lot that arrived with a slumped cake. Without an identifier linking result to preparation to lot, that question is unanswerable and the anomaly stays unexplained.

A handwritten label on a vial is a pointer, not a record. It rubs off, it fits four fields at most, and it does not survive the vial. The record lives in the notebook or the system; the label carries the identifier and the date and points back to it.

Fields worth capturing at the moment of preparation

None of this is burdensome once it is a template rather than a decision. The whole set fits on a few lines, and the discipline it enforces is mostly that the arithmetic gets written down at the moment it is performed, which is when an error is still cheap to catch. A stock with a complete record can be compared against another stock, across lots and across suppliers; a stock without one can only be compared against itself, and only for as long as memory holds. The difference between those two positions is the difference between a result that can be defended and one that can only be repeated and hoped for.

Questions this guide gets asked

Where to read next

• Bacteriostatic water for research peptides what the diluent itself contributes, and how the choice changes a stock
• How to review a peptide certificate of analysis where the peptide content and water figures behind the correction live
• Peptide storage and handling for laboratory research what happens to the stock once it is prepared
• Bacteriostatic water, 3 mL benzyl alcohol preserved diluent for laboratory reconstitution work
• Third-party lab testing and COAs